NRx Pharmaceuticals underwriters exercise overallotment, purchase 91,050 shares at $3.30

NRX Pharmaceuticals, Inc.

Underwriters exercised option to buy 91,050 additional shares at $3.30 per share from previously announced offering.
Gross proceeds from overallotment approximately $300,465; closed May 23, 2024.
Overallotment exercise completed; shares issued at same price as initial public offering.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.